Collector
Giriş Yap
Cancer drug startup Parabilis Medicines is raising a record $670 million in its IPO | Collector
Cancer drug startup Parabilis Medicines is raising a record $670 million in its IPO

Cancer drug startup Parabilis Medicines is raising a record $670 million in its IPO

The Cambridge, Massachusetts-based biotech priced 33.5 million shares at $20 each, topping the $625 million raised by Kailera Therapeutics in April

Go to News Site